Additionally, it has been shown that CDKN2A mutations that cause loss of function in somatic cells are linked to lung, head and neck, gastroesophageal, melanoma, stomach, colon, and non-small cell lung cancers, indicating that CDKN2A is involved in a number of tumor types [28]. Here, CDKN2A is linked to melanoma.